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Abstract
Influenza viruses have been responsible for large losses of lives around the world and continue to present a great public
health challenge. Antigenic characterization based on hemagglutination inhibition (HI) assay is one of the routine
procedures for influenza vaccine strain selection. However, HI assay is only a crude experiment reflecting the antigenic
correlations among testing antigens (viruses) and reference antisera (antibodies). Moreover, antigenic characterization is
usually based on more than one HI dataset. The combination of multiple datasets results in an incomplete HI matrix with
many unobserved entries. This paper proposes a new computational framework for constructing an influenza antigenic
cartography from this incomplete matrix, which we refer to as Matrix Completion-Multidimensional Scaling (MC-MDS). In
this approach, we first reconstruct the HI matrices with viruses and antibodies using low-rank matrix completion, and then
generate the two-dimensional antigenic cartography using multidimensional scaling. Moreover, for influenza HI tables with
herd immunity effect (such as those from Human influenza viruses), we propose a temporal model to reduce the inherent
temporal bias of HI tables caused by herd immunity. By applying our method in HI datasets containing H3N2 influenza A
viruses isolated from 1968 to 2003, we identified eleven clusters of antigenic variants, representing all major antigenic drift
events in these 36 years. Our results showed that both the completed HI matrix and the antigenic cartography obtained via
MC-MDS are useful in identifying influenza antigenic variants and thus can be used to facilitate influenza vaccine strain
selection. The webserver is available at http://sysbio.cvm.msstate.edu/AntigenMap.
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Introduction
An influenza virus is a negative-stranded RNA virus that belongs
to the Orthomyxoviridae family. There are three serotypes, A, B, and
C, of which B and C are reported to infect mammals only. The
influenza A viruses have 8 genomic segments (segment 1{8) with
varying lengths from about 890 to 2,341 nucleotides which encode
at least 11 proteins: PB2 by segment 1, PB1 and PB1-F2 by 2,P Ab y
3, haemagglutinin (HA) by 4, nucleoprotein (NP) by 5, neuramin-
idase (NA) by 6, matrix protein M1 and M2 by 7, and nonstructural
protein NS1 and NS2 by 8. Among these proteins, the surface
proteins HA and NA are involved in virus attachment and cell
fusion. Both HA and NA are the primary targets for host immune
systems. The serotypes of influenza A viruses are based on HA and
NA subtypes. To date, 16 HA and 9 NA subtypes have been
reported in influenza A viruses [1]. For instance, H1N1 influenza A
virus is named since it has HA and NA recognized by HA subtype 1
and NA subtype 1 antibodies, respectively. Influenza B viruses have
8 segments while Influenza C has 7 segments. There is not yet an
HA-NA nomenclature system in Influenza B and C viruses.
The peak influenza season in the northern hemisphere is from
January to April every year. More than 100,000 hospitalizations
and 30,000 deaths are caused by influenza in the United States
each year [2,3]. The influenza A virus may cause a pandemic
disaster that will impact multiple continents. In the 20th century,
three influenza A pandemics occurred in 1918, 1957, and 1968,
respectively [4,5]. More than 40 million people were killed in the
1918 influenza pandemic, which was caused by the H1N1
influenza A virus. This influenza pandemic shortened global life
expectancy by more than 10 years. During March and early April
2009, a new H1N1 influenza A virus epidemic was detected in
Mexico and the United States [6], and the virus spread rapidly
through human-to-human transmission, resulting in WHO
declaring a pandemic, which was the first influenza pandemic in
the past 40 years. This virus was estimated to cause about 57
million infections and 11,100 deaths solely in United States
through Jan 14, 2010 (www.cdc.gov). If we consider all cases in
five continents, the numbers will become significantly larger.
In the United States, vaccination is the primary option for
reducing the effects of influenza. The seasonal influenza vaccines
used in the past decades include three viral components: H1N1
influenza A virus, H3N2 influenza A virus, and influenza B virus.
In an effective vaccination program, vaccine strain selection will be
the most important step since the highest protection could be
achieved only if there is an identical antigenic match of the vaccine
and epidemic virus HA and NA antigens, especially HA, which is
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RNA virus, influenza A virus has rapid mutations in these two
proteins, and such mutations can cause a change of antigenicity,
thus making vaccines ineffective. Mutations in HA and NA are
also referred as antigenic drift.
Immunological tests, such as hemagglutination inhibition (HI)
assay, enzyme-linked immunosorbent assay (ELISA), and micro-
neutralization assay, have been utilized to identify antigenic
variants among the circulating influenza strains. Among these
assays, HI, has been one of the routine procedures in influenza
vaccine strain selection. HI assay is an experiment to measure how
a testing influenza antigen (virus) and a reference antiserum
(antibody) react. The antibody is usually diluted in 5 fold first and
then diluted in powers of 2. Thus, the titre from HI assay will be
5|2n, n§0. The larger the n is, the more closely the testing
antigens match the reference antigens, for which the reference
antisera are generated. Usually a number smaller than 20 is
considered as a low reaction between antigen and antibody. In
many cases, HI experiments are used to measure the antigenic
distance between two testing antigens through their immunolog-
ical reactions to the same reference antiserum. For instance, if one
testing antigen is a high reactor for the reference antiserum (e.g.
with a titre of 320) while another testing antigen is a low reactor
(e.g. with a titre of 40). The antigenic distance could be
approximately 3 units, which is log2(320=40). In reality, the
antigenic distances are usually measured by a set of reference
antisera, thus the calculation is much more complicated. Such
measurements from HI data are generally used to determine the
antigenic distances between testing antigens.
In a typical influenza HI assay, generally less than 15 reference
antisera are used but the number of test antigens can be more than
100. However, interpretations of HI results are not straightforward
due to the following two challenges: (1) HI assay only shows the
indirect relationship between antigens and antisera since each value
reflects a reaction from antigen, red blood cell (RBC), and antibody.
Many variables from RBC and antibody will interfere the HI titres;
(2) it is not be possible to perform HI for all pairs of antigen and
antisera reactions. Thus, the resulting HI table is generally
incomplete, and the percentage of missing data could be up to
95%. By applying the metric multidimensional scaling method
(MDS) to reduce the shape space into less than three dimensions,
Lapedes and Farber [7] showed a linear correlation between
logarithm values of HI titers and the space distances between
influenza antigens. Based on this method, Smith et al. [8]
constructed influenza cartography to visualize the distances among
influenza antigens from HI tables by further developing the metric
MDS method. Their method assumes that antigens and antibodies
are mapped into the same low-dimensional space, and their
interactions are the distances between the embedded points.
However, in our implementation of their algorithm, the resulting
influenza cartography depends on the initial values selected, and
thus may not be stable. Moreover, this method results in
cartographies in which global distances may contain relatively large
errors. This is because the algorithm does not incorporate temporal
modeling to reduce the inherent temporal bias in HI tables. The
temporal bias is caused by the fact that HI table entries are not
missing uniformly at random, and off diagonal entries are more
likely to be missing or become low reactors (Figure 1). The
underlying biological reason for this bias can be explained by the
herdimmunityeffect,whereinfluenzaantigensevolverapidlyunder
the accumulating immune pressures of human population [9]. A
more detailed illustration of this phenomenon will be given later.
The goal of thispaper istopresent a computational frameworkfor
influenza cartography construction which we call Matrix Comple-
tion-Multidimensional Scaling (MC-MDS). An important aspect of
this framework isthat temporal modeling can be easily incorporated,
which as we shall show, is useful for dealing with HI tables with herd
immunity induced temporal bias. Our framework includes two
integrated steps: (1) a low rank matrix completion algorithm is first
employed to fill in the entries of the HI matrix; (2) a MDS algorithm
is utilized to map the antigens (or similarly, antibodies) into a two
dimensional space for visualization. Our approach explicitly
separates the visualization (cartography) step from the matrix
completion step, making it easier to incorporate temporal models.
Our experience shows that while temporal modeling is beneficial in
both steps, it is less important in the first step, for which we may
simply employ a sliding window approach; however it is more
essential in the second step, for which we propose a more complex
herd-immunity temporal regularization model as described in the
Materials and Methods section. The reason for the difference is that
the inherent temporal bias tends to give rise to incorrect global
distances if not handled explicitly, and thus affect the 2D
cartography process more significantly. The two step procedure in
ourapproachisthusflexibleinthefirststep,wherewecansimplyuse
a standard low rank matrix completion algorithm. On the other
hand, we have to pay special attention to temporal modeling in the
second step, whichis essential for accurate cartography construction.
Both simulation and a practical application in H3N2 influenza A
viruses demonstrate that this method is able to overcome some
limitations in the original metric MDS method of [8] and it results in
better influenza antigenic cartographies from HI data. Therefore the
proposed framework can potentially facilitate more accurate
interpretation of HI data in influenza surveillance as well as more
accurate identification of influenza antigenic variants. Both are
essential for influenza vaccine strain selection.
Results
While greater details are given in the Materials and Methods
section, we shall summarize the most important observations and
intuitions in our computational framework before presenting the
actual experimental results.
Characteristics of HI data
In this work we are specifically interested in HI datasets existing
accumulating original, such as the immunological datasets of human
origin. In a typical HI dataset, three types of data entries are present:
Type I, a regular HI titre; Type II (low reactors), the value is defined as
‘‘less than a threshold’’, e.g. vthreshold and this threshold is caused
Author Summary
Influenza antigenic cartography is an analogy of geo-
graphic cartography, and it projects influenza antigens
into a two- or three-dimensional map through which we
can visualize and measure the antigenic distances
between influenza antigens as we visualize and measure
geographic distances between the cities in a geographic
cartography. Thus, influenza antigenic cartography can be
utilized to identify influenza antigenic variants, and it is
useful for influenza vaccine strain selection. Here we
develop a new computational framework for constructing
influenza antigenic cartography based on hemagglutina-
tion inhibition assay, a routine antigenic characterization
method in influenza surveillance and vaccine strain
selection. This method can be used for antigenic
characterization in vaccine strain selection for both
seasonal influenza and pandemic influenza.
Influenza Antigenic Cartography Construction
PLoS Computational Biology | www.ploscompbiol.org 2 October 2010 | Volume 6 | Issue 10 | e1000949by the lower bound experimental limit in HI assays indicating a weak
(or low) immunological reaction between a testing antigen (virus) and
an antiserum (antibody); Type III, missing values. A major
characteristic of HI dataset is that the distributions of type I, type II,
and type III data are not random. Specifically, if we arrange both
antigens and antibodies in a HI matrix according to time, then there is
a banded structure, where most Type I data appear very close to the
diagonal of the matrix; Type II data tend to be slightly off diagonal,
while Type III data are more likely to occur in matrix entries that are
significantly off diagonal (Figure 1). This data characteristic introduces
a ‘‘temporal bias’’ concerning the data distribution (in comparison to
uniformly random distribution) that needs to be corrected. As we will
show, if the problem is not handled appropriately, then inaccurate
result will be produced. This is because classical methods assume
uniformly random data distribution, which does not take the temporal
bias effect into consideration. Our paper shows that temporal
modeling, which reduces the data distribution bias in HI tables, is
important in HI based influenza cartography.
The specific benchmark dataset used in our study includes
4,215 entries, representing 19:56% of all table entries (Figure 2).
Among these entries, 937 (22:2%) are Type II values (that is, they
are recorded as vthreshold) with threshold [f5,10,20,40g. For
algorithmic comparison purposes, we also include results on a
simulation dataset with ground truth, which is generated
according to characteristics of real HI datasets.
Sliding-window procedure for matrix completion
As pointed out above, most Type I data are located across the
diagonal line of the HI matrix, which significantly deviates from the
‘‘missing uniformly at random’’ assumption in classical matrix
completion. In order to reduce this bias, we adopt a sliding window
approachwhereeachlowrankmatrix completion will beperformed
in a HI sub-matrix, which has fewer amount of Type II and Type
III data that more closely satisfy the ‘‘missing uniformly at random’’
assumption. The remaining entries that are not covered by the
(sliding window) sub-matrices can be filled with a global matrix
completion algorithm – those entries will be predicted with less
accuracyduetothe banded-structure oftheHIdata thatviolatesthe
‘‘missing uniformly at random’’ assumption.
The windows are based on the temporal spans of influenza A
viruses. In order to complete the entire matrix, the algorithm will
slide yearly along with both the dimensions of antigens and
antisera to ensure the time difference between all antigens and
antisera are within a certain window size. In order to obtain an
optimal window size and best rank in matrix competition, we
tested six different sizes, including 4, 8, 12, 16, 20, and 24, and
ranks 2 to 10.A10-fold cross validation suggested that the time
frames of 12-year and 16-year with rank 6 are two best ones
towards achieving the lowest RMSE (root mean squared error)
value in matrix completion of H3N2 dataset (Table 1). The
average RMSE from 12-year experiment is slightly better than
that from 16-year experiment. Both the average RMSE for 12-
year and 16-year experiment are better than that from the entire
HI matrix. Thus, during matrix completion, a window of 12 and a
rank of 6 will used. Similarly, our optimization method
demonstrated that the window size of 3 and the rank of 2 are
the best parameters for our simulation data.
Herd-immunity MDS model for antigenic cartography
construction
After the matrix completion step, we need to project the
influenza antigens onto a two-dimensional (2D) map. In order to
Figure 1. The hemagglutination inhibition (HI) data in temporal order. High reactor are in the diagonal zone, and the low reactors and the
missing values will appear more when the approaching the challenge zone.
doi:10.1371/journal.pcbi.1000949.g001
Influenza Antigenic Cartography Construction
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in MDS based on the fact that the influenza antigens continue to
evolve under the accumulating immune pressures of human
population [9]. In order to evade the herd immunity, an influenza
virus will most likely evolve into a strain with different antigenicity
from recently circulating strains in human population. This
intuition is mathematically incorporated in our temporal MDS
model, where we assume that on the 2D cartography, influenza
viruses tend to evolve along (approximate) straight-line segments
during short time spans; that is, they tend to evolve in directions as
far away from recently appeared viruses as possible. The detailed
mathematical formula is presented in the Materials and Methods
section.
In HI tables, a Type II value is resulted from experimental
limitation of HI assay and reflects a weak (or low) immunological
reaction between a testing antigen/antiserum pair. Although this
value is not as informative as a Type I value, it is more useful than
a Type III value (missing value). In particular, if a particular virus
has type I values with a certain set of antibodies that show strong
reactions, while another virus reacts weakly with the same set of
antibodies (resulting in type II values), then the global distance
between their 2D cartography embeddings should be relatively
Figure 2. Data distribution in the H3N2 HI dataset. Three types of data are present in HI data: type I, a regular HI titre marked in red cross; Type
II, the value is defined as ‘less than a threshold’, e.g. vthreshold, where threshold [f5,10,20,40g, and these values indicate the testing antigen and
antiserum have a weak (or low) immunological reaction. Type II values are marked in green diagonal cross; Type III, missing values, which are blank.
This HI dataset includes 4,215 entries, which represent 19:56% data presence. Among these entries, 937 (22:2%) are Type II values.
doi:10.1371/journal.pcbi.1000949.g002
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this observation. The details can be found in the Materials and
Methods section.
There are four parameters l1,l2,p1,p2 to be optimized in our
temporal MDS model. We use 10-fold cross validations to select
the optimal parameters that achieve the lowest RMSE while
satisfying global distance constraints derived from Type II data.
Our cross-validation results led to l1~6, l2~11, p1~3, p2~10
for the real data and l1~6, l2~11, p1~1, p2~3 for the
simulation data.
Influenza cartography construction using simulation data
To demonstrate the potential impacts of Type II data (low
reactors) and Type III data (missing values) on the influenza
cartography, we performed experiments using simulated HI
matrices containing 200 antigens versus 100 antibodies in which
we know the ground-truth. Three simulated HI matrices were
generated, where one was based on the distributions of H3N2
1968–2003 HI data: (1) HI matrix (0% data absence) with neither
Type II nor Type III data; (2) HI matrix (80% data absence, data
structure: randomly distributed) with Type III data but without
Type II data; (3) HI matrix (80% data absence, data structure:
with a temporal data missing bias similar to H3N2 data as shown
in Figure 2) with both Type II data and Type III data. The first HI
matrix serves as the benchmark data (ground truth). The second
HI matrix is used to test the efficiency of standard matrix
completion algorithms under the missing uniformly at random
assumption. The third matrix is used to examine the efficacy of the
temporal model in MDS. A more effective computational method
would be expected to produce a cartography more similar to that
of the benchmark matrix. Using these simulated HI matrices, we
are able to compare the MC-MDS method proposed in this work
to the original metric MDS method of [8] in terms of HI matrix
completion and cartography construction accuracies.
To assess whether MC-MDS and metric MDS can accurately
recover the HI values in the HI data, we calculated the local
RMSEs for the Type I data using 10-fold cross validation (Table 2).
The experimental data were partitioned into 10 parts, and each
time we use 9 parts for training and 1 part for testing. The RMSE
values were calculated using the Type I values in the testing part.
Here we only use Type I values for RMSE calculation in order to
be consistent with our real-data experiment, where we do not
know the ground-truth corresponding to Type II and Type III
data. The local RMSE values were 1:5803+0:0840 for MC-MDS
and 1:5723+0:1519 for metric MDS, where the notation of
mean+standard deviation is used. Since a typical matrix value is
about 6:0604+2:7420, these local RMSE values indicate that
both methods were able to recover HI values effectively. The small
Table 1. The local RMSE values from 10-fold cross validations using H3N2 HI dataset (1968–2003) with different window sizes (W)
in sliding window based Alternating Gradient Descent.
Rank
W 234567891 0
44 :9546 3:4243 15:9876 ––––––
81 :9596 1:4266 1:4396 1:4329 1:6786 2:1325 19:8018 3:7417 12:7570
12 1:6436 1:2204 1:1721 1:1001 1:0503 1:1593 1:2159 1:3143 1:2694
16 1:6594 1:2579 1:1894 1:0845 1:0613 1:0939 1:1737 1:2137 1:3267
20 1:6749 1:3389 1:2218 1:1217 1:1635 1:1975 1:1200 1:1095 1:1646
24 1:6062 1:3289 1:1605 1:2063 1:2329 1:1803 1:1518 1:1520 1:1900
doi:10.1371/journal.pcbi.1000949.t001
Table 2. Comparison between MC-MDS and metric MDS.
HI recovering Cartography construction
Local RMSE
1 Robustness Global distance measurement
Correlation coefficient
(CC value)
2
Maximum distance
(MD value)
3
Pairwise distance RMSE
(PD value)
4
Simulation MC-MDS 1:5803(0:0840)
5 0:9922(0:0044) 17:3843(1:7342) 1:7761(0:1304)
Metric MDS 1:5723(0:1519) 0:8831(0:1318) 26:7597(4:4159) 3:3219(0:7724)
H3N2 MC-MDS 1:0503(0:0840) 0:9816(0:0196) 17:4676(0:9339) —
Metric MDS 1:0469(0:0850) 0:7393(0:1654) 23:3253(3:5090) —
1HI recovery ability is assessed by calculating the RMSE values on the Type I data using 10-fold cross validation, and these values are also called local RMSEs.
2A correlation coefficient (CC value) is calculated from the pairwise distances among antigens for every two independent runs. The CC values in this table were
calculated from 100 different runs.
3A maximum distance (MD value) refers to the difference between the maximum distance among any antigens in the benchmark cartography and that from the
method being evaluated (either MC-MDS or metric MDS). The MD values in this table were calculated from 100 different runs.
4A pairwise distance RMSE (PD value) is the difference between the pairwise distances among all antigens in the benchmark cartography and those from the method
being evaluated. The PD values in this table were calculated from 100 different runs. The PD values for H3N2 data were not assessed since we do not know the ground
truth of antigenic cartography for this dataset.
5The value in the bracket is the standard deviation of the associated parameter.
doi:10.1371/journal.pcbi.1000949.t002
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is significantly smaller than the standard deviations. Hence they
are statistically insignificant. However, we note that metric MDS
has a larger standard deviation, which is consistent with our
observation that it is less stable.
The effectiveness of a cartography construction algorithm can
be assessed using figures of merit that measure its robustness and
correctness. The robustness of a method is determined by the
correlation coefficient (CC value) that is calculated from the
pairwise distances among antigens for every two independent runs.
The correctness of cartography is measured by two values: the
difference between the maximum distances (MD value) between
any antigens in the benchmark cartography and that from the
method being evaluated (either MC-MDS or metric MDS); the
pairwise distance RMSEs (PD value), calculated by measuring the
difference between the pairwise distances among all antigens in the
benchmark cartography and those from the method being
evaluated. We performed 100 independent runs, and the mean
and standard deviation for each figure of merit can be found in
Table 2.
As specified in the Materials and Methods section, the matrix
completion method employed in this paper was Alternating
Gradient Descent (AGD). In Figure 3, the ground-truth cartog-
raphy is given in Figure 3a. Figure 3b shows a typical result when
matrix entries are missing uniformly at random (the second matrix
generated in our simulation study), where the standard AGD
Figure 3. Computational simulation demonstrates that temporal model can reduce the biases generated by the Type II data (low
reactors) in hemagglutination inhibition (HI) dataset. (a) HI matrix (0% data absense) with neither Type II nor Type III data, using
multidimensional scaling (MDS); (b) HI matrix (80% data absense, data structure: randomly distributed) with Type III data but without Type II data,
using Alternating Gradient Descent (AGD) and MDS; (c) HI matrix (80% data absense, data structure: similar to H3N2 data as shown in Figure 1) with
both Type II data and Type III data, using AGD and MDS; (d)HI matrix (80% data absense, data structure: similar to H3N2 data as shown in Figure 1)
with both Type II and Type III data, using MC-MDS. (e)HI matrix (80% data absense, data structure: similar to H3N2 data as shown in Figure 1) with
both Type II and Type III data, using Metric MDS. (f) Another independent run by the same setting and method as (e).
doi:10.1371/journal.pcbi.1000949.g003
Influenza Antigenic Cartography Construction
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cartography is similar to that from the benchmark matrix.
Figure 3c shows a typical result with temporally biased HI table
(the third matrix generated in our simulation study), where the
cartography was constructed from a combination of AGD for
matrix completion and the conventional MDS (without temporal
modeling) for cartography generation. It shows that this
combination is unable to accurately recover the cartography of
the benchmark data since the global distances are incorrect. In
comparison, the combination of AGD with temporal MDS, shown
in Figure 3d, does achieve significantly more accurate global
cartography. This experiment demonstrates the need to explicitly
incorporate temporal modeling into the MDS step. Moreover, our
experiment shows that cartographies generated by AGD and
temporal MDS are stable. The CC value and PD value for the 100
independent runs are 0:9922+0:0044 and 1:7761+0:1304,
respectively. The MD value for the 100 independent runs is
17:3843+1:7342, which is close to the ground-truth value of
17:6108 in the benchmark cartography (Figure 3a).
For comparison, we implemented the metric MDS method of
[8] and applied to the third HI matrix which was generated with
temporally biased data type distributions. Our results indicate that
the cartographies from metric MDS are less stable, with two
typical runs given in Figure 3e and 3f. In the 100 independent runs
of metric MDS, the CC value and PD value for the 100
independent runs are 0:8831+0:1318 and 3:3219+0:7724. The
MD value is 26:7597+4:4159. These numbers are significantly
worse than the corresponding numbers from the MC-MDS
method proposed in this work. We shall especially note that the
metric MDS method tends to over-estimate the global distances in
this stimulation study. Moreover, the large standard deviations in
the results also indicate that metric MDS is not very stable.
While these two methods achieve similar matrix completion
accuracies, the reconstructed cartographies reveal a more
significant difference. As we pointed out earlier, this is because
the temporal bias (of data type distribution) in HI tables has
stronger impact in the MDS step, especially when we compare
global distances. Without temporal modeling, the accuracy of
global distances between two points (representing two viruses) in
the 2D cartography decays more rapidly when the two points
become further apart in time. While this reduction of accuracy is
an unavoidable limitation of the banded structure in HI tables
(Figure 1) that makes it harder to reliably compare points far away
in time, a good temporal model can alleviate its impact, and thus
increase the accuracy of the resulting cartography.
Finally we summarize the main observations from this simulation
study as follows. Both MC-MDS and metric MDS methods
achieved similar accuracy in recovering HI values. This means
that they achieve comparable performance in the matrix comple-
tion sub-task, which is less sensitive to the temporal bias problem in
HI tables. However, without temporal modeling, the global
distances among far away points in the reconstructed cartography
become inaccurate. Therefore it is helpful to incorporate temporal
modeling into the MDS step in order to reduce the temporal bias
effect. The proposed MC-MDS framework (with herd-immunity
temporal model) is effective in reducing the bias problem, and it
leads to more accurate cartography. The metric MDS appears to be
less stable and it generates less accurate cartographies because the
method does not address the temporal bias problem.
Influenza antigenic cartography for H3N2 influenza A
virus
In the second experiment, we use MC-MDS to construct
influenza cartography for H3N2 influenza A viruses from 1968 to
2003 using the HI datasets from Smith et al. [8]. The antigenic
map is shown in Figure 4. The scale of antigenic cartography is
based on the antigenic distances from HI tables, e.g. each unit
(grid) in the antigenic cartography represents of a 2-fold change in
HI titres. These viruses are specifically labeled as eleven clusters
(HK68, EN72, VI75, TX77, BK79, SI87, BE89, and BE92,
WU95, SY97, and FU02). Our results indicate that the antigenic
distance between HK68 and FU02 is approximately 17:5 units.
The resulting cartography can be compared to the published
antigenic map in Smith et al. [8]. The overall trend in our results is
similar to the cartography from Smith et al. [8]. However, there are
two major differences: (1) The global distances in our cartography
aresmaller than those of Smith et al.[8]. For example Smith et al.[8]
showsadistanceof32 unitsbetweenHK68 and FU02.Althoughwe
have no ground truth for this data, we note that this discrepancy is
consistent with our simulation study, where the metric MDS
method also produces larger global distances. In that case, the
metric MDS method over-estimated the global antigenic distance
between A and J by 9:1489 units more than the true distance. (2)
The local cartographies between some clusters are different. For
instance,the distancebetween WU95 andBE89 fromourmethodis
larger than those shown in Smith et al. [8]. In order to examine
which antigenic cartography is likely to be more accurate, we
performed a small cartography for H3N2 HI data from 1987 to
1995. Since the number of Type II data on the HI data from 1987
to 1995 is quite small, the effects of Type II on the antigenic
cartography is minimal. Therefore, the cartography for the viruses
between 1987 to 1995 using data from the limited span will not
suffer much from the temporal bias problem discussed in the paper,
and thus should be close to the true cartography. Our result shows
that the distance between WU95 and BE89 should indeed be larger
than that between BE95 and BE92 (Figure 5), and this is consistent
with the local cartographies from MC-MDS.
Similar to the simulated HI data experiments, we can assess the
robustness of MC-MDS and metric MDS on the H3N2 data
(Table 2). The best local RMSE was 1:0503+0:0840 for MC-
MDS and 1:0469+0:0850 for metric MDS. Therefore there is no
statistically significant difference in matrix completion quality. The
CC values from the 100 independent runs are 0:9816+0:0196
and 0:7393+0:1654 for MC-MDS and metric MDS, respectively.
The MD value was 17:4676+0:9339 for MC-MDS and
17:4676+0:9339 for metric MDS. These numbers are consistent
with the simulation study, showing again that MC-MDS is more
stable for antigenic cartography construction.
From the 100 runs of metric MDS, we were not able to generate
the exact cartography in Smith et al. [8]. One reason might be that
the initial values we randomly chose were not exactly the same as
those from [8], which were not specified clearly from [8]. The source
code of our implementation of the metric MDS method in [8] is
available upon request. We shall point out that our implementation is
strictly based on what was described in[8]. While we have spent great
effort to ensure the correctness of our implementation, it is possible
that there are undocumented improvements in the optimization
algorithm used to solve the metric-MDS problem. In such case, their
actual implementation might not suffer from the issues observed in
our study. Nevertheless it is still useful for us to examine problems of
the algorithm presented in their original paper, the underlying causes
of these problems and their potential mathematical remedies. This is
what this study tries to achieve.
Discussions
Each year, about 80 World Health Organization (WHO)
collaborating laboratories and 70 National Respiratory and
Influenza Antigenic Cartography Construction
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throughout the United States participate in virologic surveillance
for influenza. By collaborating with over 110 other National
Influenza Centers in the WHO Global Influenza Surveillance
Network, the vaccine strains for next influenza season are
determined in the middle of February each year for northern
hemisphere (these strains are used as vaccine strains in the United
States) and September for southern hemisphere. The pandemic
vaccine strains are also selected through collaborative efforts
among different laboratories across the WHO Global Influenza
Surveillance Network. Influenza vaccine strain selection is a very
labor intensive procedure that depends on both antigenic
characterization and genetic characterization. In general, whether
an isolate will be sequenced or not is based on the result from
antigenic characterization, and only highly potential antigenic
variants are sequenced. Therefore, antigenic characterization is
critical for vaccine strain selection. In order to identify a potential
influenza vaccine strain, we have to integrate the HI tables from
different experiments in the same laboratories or even from
different laboratories. Each experiment only includes up to 15
reference antisera, which are updated at each influenza season or
even each month within the same influenza season. In addition, it
is common for individual laboratories to use different antisera.
Therefore, the integrated HI table is typically an incomplete
matrix. This incompleteness and the limitation of HI experiments
(see the introduction section) present a challenge in interpreting HI
results and thus antigenic variant identification. Another impor-
tant challenge of HI data is the temporal bias effect, which means
Figure 4. The influenza antigenic cartography constructed by MC-MDS for H3N2 viruses from 1968 to 2003. The 253 viruses labeled
with the cluster names HK68, EN72, VI75, TX77, BK79, SI87, BE89, BE92, WU95, SY97 and FU02 are defined by [8]. One unit (grid) corresponds to a two-
fold change in HI assay.
doi:10.1371/journal.pcbi.1000949.g004
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(Figure 1). These are the problems this paper addresses.
As an analog of geographic cartography, influenza cartography
can be used to visualize and measure antigenic distances between
influenza viruses. An essential criterion for a new influenza vaccine
strain is significant antigenic divergence (e.g. 4 fold change in HI
test) from the current vaccine strain. Influenza antigenic
cartography can help us identify whether a testing antigen (virus)
is antigenically far away from a specific vaccine strain or a specific
cluster of antigens (e.g. circulating strains at a specific time period).
In this study, we proposed a new computational framework for
constructing an influenza antigenic cartography, and demonstrat-
ed its usefulness in antigenic characterization. This computational
framework has two integrated steps: (1) through a matrix
completion algorithm, influenza antigenic distance matrices are
constructed; (2) through MDS (with herd-immunity temporal
model), influenza antigens (viruses) are projected onto a two-
dimensional cartography. We specifically pay attention to the
major challenge that is caused by the temporal bias in HI datasets.
That is, the banded structure of HI entries indicates that the
matrix entries are not missing uniformly at random (Figure 1),
which violates the standard assumption in conventional methods.
Our experiment showed that standard approach will not handle
this problem very well, and will produce cartographies with
incorrect global distances. This paper addresses the problem
through a biologically motivated temporal evolution model that is
Figure 5. The antigenic cartography by MC-MDS for H3N2 HI data from 1987 to 1995. The influenza viruses labeled with the cluster names
SI87, BE89, BE92, WU95 are defined by [8]. One unit (grid) corresponds to a two-fold change in HI assay. This data is a subset of the HI data shown in
Figure 2.
doi:10.1371/journal.pcbi.1000949.g005
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that more accurate antigenic distances can be obtained from this
approach.
Although MC-MDS is presented as a 2D cartography
construction method in this paper, it can be extended easily for
3D (or even higher dimensional) cartography by modifying the
resulting cartography dimension in the MDS step of our
computational framework.
The temporal regularization in MC-MDS is based on the fact
that the influenza antigens continue to evolve under the
accumulating immune pressures of human population [9]. Within
a short time period, the antigenic distances among viruses tend to
become larger in temporal order. Such a regularization is
important since it can effectively minimize the biases of Type II
data. However, such regularization does not necessarily imply that
the antigen would always evolve forward. Theoretically, it is
possible that the antigenicity (not genetic sequence) of influenza
viruses could become similar to earlier circulating strains when the
selective pressure from herd immunity disappears. This is
supported indirectly by the report that 2009 pandemic H1N1
virus cross-reacted with the serum from the ages over 60, who
were likely to infect the seasonal H1N1 virus circulating in human
population before 1957 [10].
Besides the immunological datasets for the influenza viruses
(such as those of human origin) with the accumulating immunity
from their hosts, there are other immunological datasets for the
influenza viruses from mutations (not necessarily accumulating
immunity), such as those of swine or avian origin. For the latter
case (e.g. the data of swine or avian origin), our limited
experiments in H5 and H7 studies suggested that the users can
use MC-MDS directly without temporal model (data not shown).
However, there might be additional structures to explore in such
data. This requires more extensive investigations in the future.
Conclusion
We introduced a new computational framework for influenza
antigenic cartography construction from HI datasets. This
approach, which we refer to as MC-MDS, integrates two
mathematical procedures: matrix completion and MDS projection
(with temporal modeling). Using the AGD matrix completion
algorithm on HI datasets from 1968 to 2003, we successfully
identified the eleven reported clusters of antigenic variants that
represent major antigenic drift events during these 36 years. Thus,
this method is useful in both influenza antigenic variant
identification and influenza vaccine strain selection. Our results
also demonstrated that MC-MDS is more robust and effective
than our implementation of the metric MDS method [8] in
influenza antigenic cartography construction.
Materials and Methods
Dataset and data transformation
H3N2 HI benchmark dataset and data transformation.
The benchmark HI dataset is adopted from [8], and it includes
4,215 observed HI values from the reactions from 273 H3N2
influenza A viruses against 79 ferret antisera. These viruses were
isolated periodically from locations around the world between
1968 and 2003, and the antisera were generated against 79
prototype influenza strains, most of which were selected from these
273 influenza isolates. Both influenza antigen (virus) and antiserum
(antibody) can be roughly clustered into eleven groups, HK68,
EN72, VI75, TX77, BK79, SI87, BE89, BE92, WU95, SY97 and
FU02, which represent the eleven major events of antigenic drifts
resulting in a pandemic or an epidemic from 1968 to 2003. For
instance, FU02 represents a group of influenza viruses isolated
around the year of 2002 with similar antigenic characteristics.
Within this dataset, three types of data points are present: Type
I, a regular HI titre; Type II, the value is defined as ‘less than a
threshold’, e.g. vthreshold, where threshold [f5,10,20,40g, and
this value represents the testing antigen and antiserum do not
strongly react with each other; Type III, missing values. Following
[8], we preprocess the HI matrix by normalizing the data entries
as follows: each Type I entry with the observed value mij is
transformed to qmax(Hij)r{log2
max(Hj)
Hij
  
, where max(Hij) is
the largest HI value among all observed entries and max(Hj) is the
maximum HI value for antiserum j; each Type II entry with value
vthreshold is transformed into qmax(Hij)r{log2
max(Hj)
Threshold
  
;
Type III data are replaced with 0 s, representing the missing
values.
Simulated HI data. To study the effect of temporal bias on
influenza cartography, we simulate HI matrices with DVD viruses
and DAD antibodies. Both the viruses and antibodies can be
partitioned into t blocks by temporal information. In each
block, we will have 20 viruses and 10 antibodies. Let HIti,t’j
denote the HI titre for Vti and At’j, where tƒ10, t’ƒ10, 0viƒ20,
and 0vjƒ10. Each HIti,t’j is a random value generated uniformly
from f5|211{D3|(t{t’)D,5 |211{D3|(t{t’){1D,5 |211{D3|(t{t’){2D,
5|211{D3|(t{t’){3Dg.
In the HI matrix with Type II values, all the HI values no more
than a titre of 20 will be replaced with Type II values of the form
ƒ20. The matrix is preprocessed according to the same method
used in the H3N2 HI benchmark dataset. To generate incomplete
HI matrices, we randomly select Type I and Type II HI values
(about 20%) from the entire HI matrix by mimicking the data
distribution in the H3N2 HI dataset.
Matrix completion algorithms
The goal of matrix completion is to fill the missing entries in an
incomplete matrix based on appropriate mathematical models of
the matrix. It is a traditional mathematical problem that has been
studied for many decades. Early contributions on this problem
include Schur [11], Farahat and Ledermann [12], Friedland [13],
Hershkowitz[14],LondonandMinc[15],Mirsky[16] and Oliveira
[17–19]. In the past decade, interest in the problem has grown
substantially, especially after the launch of Netflix competition [20]
in 2007. The Netflix problem is to predict each user’s movie
preference (in order for Netflix to make appropriate movie
recommendations to each user) from approximately 1% observed
user ratings. This can be regarded as a matrix completion problem,
where we predict missing user/movie ratings from incomplete
observations. This is exactly like the problem of predicting antigen/
antibody interactions which we consider in this paper. In general,
matrix completion is ill-posed and computationally intractable
[21,22]. However, recently, Candes and Rect [22] and Recht et. al
[23] proved that under appropriate conditions, the minimum rank
matrix solution can be recovered from incomplete entries by solving
a convex optimization problem. These theoretical developments
generated further interest, and afterwards, a number of new
methods have been proposed [24–30].
If we do not consider the temporal bias effect, then the antigenic
cartography task can be formulated as a matrix completion
problem. Simply, in an HI matrix, there are m antigens
corresponding to the rows, and n antisera corresponding to the
columns. Let mij denotes the HI value from the reaction between
testing antigen i and antiserum j. The HI matrix can be
Influenza Antigenic Cartography Construction
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Mm|n~(aij)m|n:
Let E denote the subset of M’s entries corresponding to Type I
and Type II data. In practice DED%m|n. The goal of matrix
completion is to estimate the HI values in the Type II and Type III
entries as accurately as possible. In addition, matrix completion
can re-estimate Type I entries and remove embedded noises,
which were from the uncertainties in experimental measurements.
This is a standard matrix completion problem. The standard
approach to this problem is to assume that the matrix is low rank,
with rank r%min(m,n). In our application, this means that each
antigen i can be embedded into the r-dimensional space as ui, and
each antiserum j can be embedded into the r-dimensional space vj.
In the low rank model, the interaction aij between antigen i and
antiserum j is given by uT
i Sr|rvj for some matrices Sr|r. We can
aggregate vectors ui into a matrix Um|r and aggregate vectors vj
into a matrix Vn|r. Mathematically, the low-rank model is to find
matrices U with dimensions m|r, V with dimensions n|r and a
diagonal matrix S with dimensions r|r such that
M~Um|rSr|r(Vn|r)
T: ð1Þ
Here we describe AGD matrix completion method, which is
developed based on gradient decent method. AGD method
assumes the low rank matrix completion model (1).
If type II data are not present, one can employ the following
optimization formulation to estimate the missing values
min
X
1
2
X m
i~1
X n
j~1
(ME
ij {XE
ij )
2zlg(X),
s:t: X~Um|rSr|r(Vn|r)
T
ð2Þ
where ME
ij ~Mij, XE
ij ~Xij when (i,j)[E and ME
ij ~0,XE
ij ~0
otherwise.
The function g(X) is a regularization condition for the matrix
X, which is introduced to stabilize the solution. The solution X of
the optimization problem (2), which does not contain any missing
value, will replace M (which has missing values) as the true (and
denoised) HI table, which we can then use for other purposes, such
as cartography construction.
In the AGD method, we take g(X)~
Xm
i~1 g1
Ui kk
2
3m0r
 !
z
Xn
i~1 g1
Vi kk
2
3m0r
 !
in (2), where g1(z)~e(z{1)
2
{1 when z§1
and g1(z)~0 otherwise. Ui (Vi) denotes the ith row of U(V) and
m0~maxfm,ng.
First, the algorithm uses SVD to obtain the factorization
ME’~USVT. Here ME’ is the trimmed matrix of ME where we
randomly set some observed values to 0 from the rows (columns)
when a row (column) contains more than 2DED=m(2DED=n) observed
values. The purpose of this trimming step is to guarantee that each
row (column) has less than 2DED=m(2DED=n) non zero values. This is
based on the observations of Keshavan et. al. [27] that when
DED~H(n), the corresponding singular vectors are highly concen-
trated on high-weight column (or row) indices. It means that those
vectors do not provide useful information. After SVD, we set the
initial value U to U0  
ﬃﬃﬃﬃ
m
p
and V to V0  
ﬃﬃﬃ
n
p
where U0 and V0
are the first r columns of U and V respectively.
We then apply the following alternating optimization procedure
until convergence orwhen certainnumber of iterationsare reached.
N Fix Uj and Vj and calculate the matrix Sr|r to minimize the
squared error
1
2
Xm
i~1
Xn
j~1 (ME
ij {XE
ij )
2. This is a least
squares regression problem with respect to Sr|r.
N Update Ujz1 (Vjz1) using gradient descent: we take steps
proportional to its negative of gradient with respect to the
objective function. That is, Ujz1~Ujzt   +Uj and
Vjz1~Vjzt   +Vj where t is the step size parameter which
can be optimized by line search algorithm.
N The first two steps are repeated until convergence or reaching
a pre-defined number of iterations.
The gradient of U and V are:
+U~((USVT)
E{ME)VSTzUQUz
lf(U,2   e(Qu1{1)2
  (Qu1{1)),
ð3Þ
+V~((USVT)
E{ME)
TUSzVQVz
lf(V,2   e(Qv1{1)2
  (Qv1{1))
ð4Þ
where
QU~
1
m
UT((ME{(USVT)
E)VST,QV
~
1
n
VT((ME{USVT)
E)
TUS,
Qu1~
Pr
j~1 U2
1j
Pr
j~1 U2
2j
. .
.
Pr
j~1 U2
mj
0
B B B B B @
1
C C C C C A
2m0r
,Qv1~
Pr
j~1 V2
1j
Pr
j~1 V2
2j
. .
.
Pr
j~1 V2
nj
0
B B B B B @
1
C C C C C A
2m0r
and
f(Xm|r,Ym|1)~Zm|r, Zij~
Xij Y(i,1)
m0r if Y(i,1)w0),
0 otherwise:
(
A general method to handle Type II values. Although
Type II data is not as informative as Type I data, they still provide
useful information. Therefore we have to modify (2) to include
type II data. First we introduce threshold values hi,j for each
entries (i,j), and let hi,j~{? if the corresponding entry is not
type II data. If an entry is type II data, we set hi,j to be the
corresponding threshold. We change the standard matrix
completion formulation (2) into the following form that
incorporates type II information:
min
X
1
2
X m
i~1
X n
j~1
(ME
ij {XE
ij )
2I(XE
i,j§hi,j)zlg(X), s:t: X
~Um|rSr|r(Vn|r)
T,
ð5Þ
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i,j§hi,j)~1 if XE
i,j§hi,j;
and I(XE
i,j§hi,j)~0 if XE
i,jvhi,j. The intuition behind this
formulation is that for an type II entry (i,j),i fXE
i,jvhi,j, then we
do not have to penalize the error (ME
ij {XE
ij )
2 because the
constraint is satisfied.
One advantage of this formulation is that we can employ any
optimization algorithm that solves (2) to solve (5). We start with an
initial estimate of X by ignoring the type II data. We then iterate
as follows until a certain number of iterations are reached:
N Let ji,j~I(XE
i,j§hi,j)
N Update X by solving
min
X
1
2
X m
i~1
X n
j~1
(ME
ij {XE
ij )
2ji,jzlg(X), s:t: X
~Um|rSr|r(Vn|r)
T
using any optimization algorithm (such as AGD) for (2).
The procedure is a principled approach to handle Type II data,
and it can be used with any algorithm that optimizes (2).
The two parameters, l in the penalty function and the rank to
project data, are trained through 10-fold cross validation. The
rank (from 2 to 10) and l (l[f0:01,0:05,0:1,1,10,100g) with the
smallest RMSE value will be selected as the best rank in matrix
completion.
Performance evaluation. The performance of matrix
completion is evaluated using the following three criteria in this
study: root mean squared error (RMSE), correlation coefficient,
and biological interpretation. Given s values fxkgk~1,...,s and
fykgk~1,...,s, we define the RMSE as:
RMSE~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ Ps
k~1 (xk{yk)
2
n
s
,
where xk stands for an observed value and yk stands for the
corresponding predicted value. If a prediction scheme has a small
RMSE value, then the predicted values are close to the true values.
For matrix completion, we utilize 10-fold cross validation to
calculate the RMSE values. The observed matrix entries are
partitioned into 10 equal parts. Each time, one part is used for
testing and the other nine parts for training. That is, each time we
use 9 parts as observed values in matrix completion; after the
completed matrix is generated from these 9 parts, we calculate the
RMSE between the completed matrix and the observed matrix
entries in the remaining part. The process is repeated for every
part in the dataset. The RMSE value is the average RMSE value
over several runs. The RMSE values were estimated only using
Type I values, and thus they are also called local RMSE. Note that
we also report the standard deviation numbers calculated from
cross validation. It is known that standard deviation calculation
based on cross validation is often smaller than the true standard
deviation; however, the numbers still provide meaningful
indications and hence are included.
For the temporal based MDS, we can define the distance
between two viruses as the Euclidean norm between the rows of
the completed HI table corresponding to the two viruses. In
evaluation, we use the local pairwise distances among temporally
close by viruses because these distances are more reliable. In
particular, the local pairwise distances are partitioned into 10
equal parts. Again, each time we left one part as testing samples
and applied temporal based MDS by using 9 parts. The RMSE
between the estimated distance and testing data are calculated,
and they are called the pairwise distance RMSEs (PD value).
The correlation coefficient (CC) between two vectors measures
the strength and direction of their linear relationship. Let
y~fy1, y2,   , yng denote the vector A and b y1 y1, b y2 y2,   , b yn yn denote
the vector B. The correlation coefficient (CC) between vector A
and B is defined as follows:
CC(y,^ y y)~
n
Pn
i~1 yib yi yi{
Pn
i~1 yi
Pn
i~1 b yi yi ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n
Pn
i~1 y2
i {
Pn
i~1 yi
   2   
n
Pn
i~1 b yi yi
2
i {
Pn
i~1 b yi yi
2
i
   2    r
Clearly, a larger CC value indicates the two vectors are closely
related. For every two runs, we will have two distance vectors and
one CC value. In 100 experiments, we will have 4,950 CC values,
then the mean and standard deviation can be calculated. This test
is to assess whether every two runs of the test method (temporal
MC-MDS or Metric MDS) are different. For instance, if metric
MDS has lower CC value and larger standard deviation, we will
conclude it is not stable.
The biological interpretation is based on separation and
quantification of the reported antigenic variant groups in the
influenza antigenic cartography.
Window size determination. In order to reduce the
temporal bias in HI matrices, we adopt a sliding window
approach in the matrix completion step. The rational for sliding
window matrix completion is that the temporal bias effect becomes
much smaller in temporally grouped sub-matrices than in the
entire HI matrix. This means that the effect of temporal bias will
be reduced when we complete each sub-matrix separately.
Therefore in our approach low rank matrix completion will be
performed separately in each HI sub-matrix. In order to complete
the entire matrix, the algorithm will slide yearly along with both
the dimensions of antigen and antisera to ensure the time
difference between all antigen and antisera are within a certain
window size W. The missing values or low reactors in HI matrix
are estimated as the mean value of the recovering values from the
associated sub-matrices. If the missing values or low reactors are
not covered by any of the sub-matrices, they will be estimated
through matrix completion using the entire HI matrix. The
selection of window size W is based on minimizing the RMSE
values from 10-fold cross validation. For H3N2 HI dataset, we
have tested different values of W [f4,8,12,16,20,24g.
Temporal based MDS for Type II data. Multidimensional
scaling (MDS) is a statistical technique widely used in information
visualization. It embeds a set of data into low dimension vectors
while preserving their pair-wise distances. The projection of
viruses into two or three dimensional space can be viewed as an
analog of a geographic cartography; thus this is referred to as
influenza antigenic cartography. Due to the temporal bias effect in
HI tables, we have to incorporate a temporal model into the MDS
algorithm to reconstruct global distances more accurately. In this
work, we consider a biologically motivated temporal regularization
criterion. The regulation in our temporal model is based on the
fact that the influenza antigens continue to evolve under the
accumulating immune pressures of human population [9]. In
order to evade the herd immunity, an influenza virus will most
likely evolve into a strain with different antigenicity from recently
circulating strains in human population. Thus, within a certain
time period (e.g. 20 years, which is within one human generation),
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temporal order.
This intuition is mathematically incorporated into our temporal
regularization condition. Specifically we assume that on the 2D
cartography, influenza viruses tend to evolve along (approximate)
straight-line segments during short time spans; that is, they tend to
evolve in directions as far away from recently appeared viruses as
possible. The concrete mathematical formulation is described
below.
First we denote by Dij the average distance between virus i and
virus j using the completed matrix from step 1, and let ti denote
the isolation year of virus i. We partition all influenza viruses
into n groups based on their temporal ordering. If a dataset covers
year c to year czn, then the n groups are viruses in year
fc,cz1g,fcz1,cz2g,   ,fczn{1,czng. This grouping choice
is due to the fact that each influenza season in the northern
hemisphere spans two years. Therefore without additional infor-
mation, it is appropriate to assign every virus to the neighboring
years as well. For instance, it is natural to assume that the A/
Beijing/32/92(H3N2) virus belongs both to group f91,92g, and to
group f92,93g. Denote by Gi the viruses in the i-th group. In 2D
cartography, we represent each virus by a two dimensional vector.
Letdij be the distancebetweenvirus i and virusj inthecartography;
let ci be the center coordinate of group i and hence daci is the
distance between virus a[Gi to the center ci,a n ddcicj is the
distance between two centers ci and cj. The temporal MDS method
in our experiments attempts to minimize the following error
function:
X
0ƒti{tjƒw
(Dij{dij)
2zl1
X
a[Gi
d2
acizl2
X
p1ƒj{i~k{jƒp2
(dcicjzdcjck{dcjck)
2:
The first term is the standard MDS. The second term means
that viruses within each group should be close to each other. The
third term is the mathematical formulation that formalizes the
biological intuition that viruses tend to evolve along straight-line
segments during short time spans.
Besides the above error function, we impose constraints on
global distances that can be derived from the original dataset. We
know that each reference antiserum is associated to an antigen. Let
the reference antiserum be ai and its corresponding antigen be vi.
If antigen vj has low reactor (Type II) with this reference antiserum
ai and antigen vk has relatively high reactor with ai, we can
naturally assume that in the 2D cartography, the distance between
vi and vk should be smaller than the distance between vi and vj.I n
our experiments, if a HI value is equal to or more than 160 (4-fold
higher than the Type II threshold 40), we call it a relatively high
reactor. The four parameters l1, l2, p1, p2 are optimized using
10-fold cross validations. The configuration that achieves the best
RMSE for reconstructing local pairwise distances while satisfying
all constraints is selected. The source codes for this implementa-
tion are available upon request.
Metric MDS for influenza antigenic cartography
construction. The metric MDS method is developed by
Smith et. al. [8] to construct antigenic cartography. This method
attempts to minimize an error function of the form
P
e(DE
ij,XE
ij ).
Here DE
ij is set to bj{log2(Hij) where Hij is the observed value
and bj is the log2 of the maximum reaction for antiserum j. The
error function is defined as
e(DE
ij,XE
ij )~
(DE
ij{XE
ij )
2 Dij [Type I data
(DE
ij{1{XE
ij )
2g(DE
ij{1{XE
ij ) Dij [Type II data
(
where g(x)~
1
1ze{10x.
Similar to AGD , this algorithm also requires a pre-defined
dimension (rank) L as input; that is, each virus or antiserum is
represented by an L-dimensional vector. Let vi~fvi1,vi2,   ,viLg
and aj~faj1,aj2,   ,ajLg represent virus i and antiserum j,
respectively. The Xij is defined as the Euclidean distance between
the vector vi and aj: Xij~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ XL
l~1 (vil{ajl)
2
q
. The algorithm
generates the random initial vector for each virus or antiserum and
the solution is found through conjugate gradient optimization with
multiple random restarts.
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